My attorney said the QOF exit is only clean if the fund manager actually wants to exit, and I have been sitting with that all week.

The secondary market for QOF interests is thin enough that "I'll just sell my position" is not really an exit plan, so you're more stuck than a typical LP who can at least shop their stake.

What does the LPA actually say about extension votes and LP consent thresholds?

The assumption doing the most work in your position is that "ten-year pitch" functions like a ten-year obligation. It does not, and you already know that. What you are really sitting with is the difference between the tax benefit vesting at year ten and the liquidity event that lets you capture it. Those are two separate moments, and the fund documents govern the second one, not the program.

The clean version of this risk is in the LP agreement. Specifically: what discretion does the GP have to extend the fund term, does extension require LP consent or just GP notice, and is there a waterfall provision that changes the GP's economic incentive if the hold runs long? A GP who earns the same promote whether they exit in year ten or year fourteen has no structural pressure to move. A GP whose carry is clipped or whose preferred return hurdle compounds against them past a certain date has real incentive to exit when the asset is ready. That is the clause worth finding right now, before the third extension mention becomes a formal notice.

The secondary risk you have not named: if the GP extends and you want out, secondary market liquidity for QOF LP interests exists but is thin and idiosyncratic. A forced secondary sale before the fund liquidates may not preserve the full ten-year appreciation benefit, and the tax treatment of a secondary transfer in the OZ context is a question for a tax attorney, not a forum. Flag that before you need it.

Your out-of-state rental analogy is structurally correct. The information asymmetry compounds over time, and by the time the problem is visible to you, the GP has already been living with it.

One specific question: does your LP agreement have a defined fund term with a fixed number of permissible one-year extensions requiring a GP certificate, or does it have open-ended GP discretion with LP notice only? That single clause determines how much real leverage you have here.

The legal obligation and the economic incentive are two different things, and conflating them is where LP anxiety usually lives.

A GP who extends to year twelve on a fund that closed in 2021 faces a real problem: the management fee runway and the carry structure both depend on a realization event eventually happening. Take a fund with a two percent annual fee on committed capital. At year ten the GP has collected twenty percent of committed capital in fees. Every year past that is revenue, yes, but it is also reputational drag and LP relationship damage on the next raise, which most GPs care about more than one extra fee year. The incentive to extend is not as clean as "they can so they will." What actually matters is whether the fund documents give LPs any consent rights on extensions, any redemption mechanism, or any removal trigger tied to timeline breach. Some do, some do not, and your attorney has already read yours.

The step-up in basis at ten years attaches to the date you held the QOF interest, not the date the fund liquidates the underlying asset. Your basis in the QOF interest itself steps up. The fund selling the property is a separate event that generates gain or loss at the fund level, passed through to you. If the fund holds past your ten-year mark without liquidating, you do not forfeit the step-up, but you cannot realize it without a liquidity event, which means the tax benefit is real but locked. That distinction is worth confirming with your tax advisor under current IRS guidance, because the mechanics here are specific.

What does the fund agreement actually say about LP consent on term extensions?

What kills me is that the step-up basis benefit already got clipped by the TCJA changes, so you are holding concentration risk and illiquidity for a 10-year hold-to-exclusion benefit that has to actually trigger. If the GP lets it run to 2033 or 2034 because cap rates have not recovered enough to make a sale pencil, your gain exclusion still works mathematically but you have been locked up four years longer than the pitch deck implied.

What does your LP agreement actually say about extension votes? Some of them require a supermajority of LP interests to approve an extension past the initial term, and that is the only real leverage you have sitting in that document right now.

The ten-year clock for the appreciation exclusion runs from your investment date regardless of when the fund sells, so a 2033 liquidity event and a 2035 one both clear that bar if you hold.

The deferred gain on the original $94k is the piece with real deadline pressure, not the appreciation exclusion, because that recognition event lands on your 2026 return whether the fund liquidates or not, and a GP extension does nothing to push that date. What you should be reading in the fund documents is whether there is a forced liquidation provision tied to any specific year, and separately whether limited partners have any supermajority right to remove the GP or trigger a wind-down vote. Those two clauses are where "no seat at the table" either holds or softens. What language does your LP agreement actually use around the fund term and extensions?